Mironid

United Kingdom
Newhouse, North Lanarkshire, United Kingdom, ML1 5UH

Company profile

Mironid company profile

Mironid is a biotechnology company that focuses on drug discovery and development. Mironid builds and advances a pipeline of drug development programs targeting cAMP-degrading phosphodiesterase enzymes. The goal is to create novel and differentiated therapies for various diseases with significant unmet medical needs. The company specializes in identifying and validating novel drug targets, particularly in therapeutic areas such as cancer and neurodegenerative diseases. Mironid's work often involves using advanced technologies and methodologies to enhance the drug discovery process, aiming to bring innovative treatments to market more efficiently.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2014-01-01, Year

Headquarters

Postal code
ML1 5UH
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$44.7M
Last funding
Series A / $38.3M / 2023-09-13
Last equity funding
Series A / $38.3M
Investors
8
Lead investors
2
Founders
3
Articles
12

Founders and investors

Founders

Miles HouslayNigel PynePaul Rodgers

Lead investors

Epidarex CapitalRoche Venture Fund

Investors

Epidarex CapitalEuropean Investment FundScottish EnterpriseSofinnova PartnersUniversity of Strathclyde